Associate Director, Discovery Biology
Caryn is Associate Director, Discovery Biology. Caryn joined Azeria in May 2018 and leads discovery biology in Azeria including cell-based pharmacology and proteomics. Caryn has over 10 years’ experience in ER and FOXA1 biology and was the first to describe the role for differential ER binding in clinical outcome in breast cancer. Caryn has a PhD from the University of Cambridge and first author of papers in journals such as Nature, Nature Genetics, and Genes and Development.